Mr. Speaker, I will make it as short as possible. I think I can give three areas where it needs to be improved. Optimal prescribing practices, public disclosure of clinical trial results, and strengthening the common drug review are three areas the government needs to consider when it gets to committee.
In the House of Commons on May 27th, 2014. See this statement in context.